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An outbreak of Acanthamoeba keratitis, a rare, poten-
tially blinding, corneal infection, was detected in the United 
States in 2007; cases had been increasing since 2004. A 
case–control study was conducted to investigate the out-
break. We interviewed 105 case-patients from 30 states and 
184 controls matched geographically and by contact lens 
use. Available contact lenses, cases, solutions, and corneal 
specimens from case-patients were cultured and tested by 
molecular methods. In multivariate analyses, case-patients 
had	 significantly	 greater	 odds	 of	 having	 used	Advanced	
Medical Optics Complete Moisture Plus (AMOCMP) solu-
tion	(odds	ratio	16.9,	95%	confidence	interval	4.8–59.5).	
AMOCMP manufacturing lot information was available for 
22 case-patients, but none of the lots were identical. Three 
unopened bottles of AMOCMP tested negative for Acan-
thamoeba spp.	Our	findings	suggest	that	the	solution	was	
not intrinsically contaminated and that its anti-Acanthamoe-
ba	efficacy	was	likely	insufficient.	Premarket	standardized	
testing of contact lens solutions for activity against Acan-
thamoeba spp. is warranted.
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A
canthamoeba keratitis (AK), a painful corneal infection 
that may lead to vision loss or enucleation, is caused by 
the ubiquitous free-living Acanthamoeba spp. (1–4). AK 
occurs primarily among users of soft contact lenses (5), 
with an estimated US annual incidence of 1–2 cases per 
million contact lens users (6).
In May 2006, the Centers for Disease Control and Pre-
vention (CDC) was contacted by the Illinois Department of 
Public Health regarding a possible increase in AK cases in 
the Chicago area during the preceding 2 years. Investiga-
tors at the University of Illinois at Chicago were conduct-
ing a case–control study to identify possible risk factors. 
In October 2006, CDC informally surveyed ophthalmolo-
gists across the country to ascertain whether cases of AK 
were increasing elsewhere; results were inconclusive. In 
January 2007, CDC initiated a retrospective survey of 22 
ophthalmology centers nationwide. By early March 2007, 
results obtained from 10 centers in 9 states showed a rise in 
the number of culture-confirmed cases during 2004–2006 
compared with 1999–2003.
On March 16, 2007, we initiated a national outbreak 
investigation. On May 23, a preliminary analysis compared 
data from the first 46 interviews of patients with culture-
confirmed AK, with data obtained from 126 healthy adult 
contact lens users ascertained in a 2006 national outbreak in-
vestigation of Fusarium keratitis (7). The analysis indicated 
that the odds of having ever used Advanced Medical Optics 
Complete MoisturePlus (AMOCMP) multipurpose contact 
lens solution were 20× greater for AK case-patients than 
for controls. These results were communicated to the Food 
and Drug Administration (FDA) and were rapidly dissemi-
nated (8). On May 26, 2007, the company voluntarily re-
called AMOCMP from domestic and international markets. 
Although public health action was taken on the basis of the 
preliminary analysis, we report here the results of a matched 
case–control study designed to verify the findings of the pre-
liminary analysis, to identify additional risk factors for AK, 
and to guide recommendations to prevent future cases.
Methods
Case Definition and Case Finding
Case-patients had been given a diagnosis of AK by an 
ophthalmologist; had symptom onset on or after January 1, 
2005; and had Acanthamoeba spp. identified from cultures 
of corneal specimens. Requests to report AK cases were dis-
seminated through CDC’s Epidemic Information Exchange 
system and through ophthalmology and optometry electron-
ic mailing lists; websites; and associations at the national, 
state, and local levels. We also queried several referral mi-
crobiology laboratories and ophthalmology centers to find 
cases. Cases included in a concurrent study by University of 
Illinois at Chicago investigators were excluded (9).
Case-Patient Data Collection and  
Laboratory Investigation
We  used  standardized  questionnaires  to  interview 
case-patients by telephone to obtain demographic charac-
teristics, information regarding illness, contact lens–related 
product use, and hygiene practices and behavior during the 
month  before  symptom  onset.  An  Internet-based  visual 
aid was available to assist with specific product recogni-
tion.  Ophthalmologists  who  were  treating  case-patients 
provided information by  telephone- or  self-administered 
questionnaires  regarding  diagnostic  methods,  treatment, 
and clinical outcomes.
Available clinical specimens (e.g., corneal scrapings 
or biopsy specimens, Acanthamoeba culture isolates) and 
environmental samples (e.g., opened and unopened contact 
lens solution bottles, lenses, lens cases) were sent to CDC 
laboratories. Specimens were processed for Acanthamoeba 
spp. by culture (4) and molecular analysis (10), including 
genotyping (11).
Case–Control Study
All  interviewed  case-patients  were  eligible.  Control 
subjects had no history of AK and were >12 years of age. 
We attempted to match 3 controls to each case-patient by 
contact lens use (i.e., soft lenses, rigid lenses, or no contact 
lens use) and by geographic location using a reverse ad-
dress directory to identify controls who resided near each 
case-patient. Because rigid lens use is uncommon, we did 
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not attempt to obtain geographically matched controls for 
this group. Controls completed a standardized, telephone-
administered questionnaire that asked about behavior and 
product use during the 1 month before their matched case-
patient had symptom onset.
Data Analysis
Data  were  double-entered  by  using  Visual  FoxPro 
8.0 (Microsoft Corp., Redmond, WA, USA) and analyzed 
by using SAS 9.1 (SAS Institute Inc., Cary, NC, USA). 
Conditional logistic regression was used to estimate odds 
ratios (ORs) and 95% confidence intervals (CIs) for uni-
variate and multivariate analyses; significance was defined 
as p<0.05. All variables that were significantly associated 
with AK by univariate analysis were further investigated 
by using a multivariate model.
Results
Descriptive Epidemiology
Case-patients  were  enrolled  during  March  16–July 
10, 2007. Of 221 AK patients identified from 37 states and 
Puerto Rico, 158 (71%) had infections that met the case 
definition. We interviewed 105 (66%) case-patients from 
30 states (Figure 1) and the treating ophthalmologists of 92 
case-patients (88%).
Times of symptom onset (Figure 2) did not show any 
obvious trends or a single period of peak exposure. The 105 
case-patients were predominantly female (67 [64%]) with a 
median age of 29 years (range 12–76 years) (Table 1). Of 
these case-patients, 93 (89%) wore contact lenses (82 [88%] 
used soft contact lenses), and 87 (94%) reported using some 
type of cleaning or disinfecting solution (78 [90%]) used 
a multipurpose solution). Of the 6 contact lens users who 
did not report use of any cleaning or disinfecting solution, 
1 used daily disposable lenses, 1 used extended-wear lenses 
that were replaced with no cleaning, 2 used only saline solu-
tion, 1 used saline solution and rewetting drops, and 1 did 
not recall which types or brands of solutions were used.
The most frequently reported symptoms among case-
patients were pain, redness, sensitivity to light, and sensa-
tion of a foreign body (Table 1). The median time from 
onset  of  symptoms  to  initiation  of  anti-Acanthamoeba 
treatment was 49 days, range 4–197 days. At the time of 
their ophthalmologist interview, 24 (28%) of 85 had either 
undergone or were awaiting a corneal transplant, and 29 
(41%) of 70 had a visual acuity of 20/200 or worse with 
best correction (i.e., legally blind) in the affected eye.
Case–Control Study
During June 14–July 10, >11,000 phone calls were 
made to obtain 184 controls matched to 91 case-patients; 
case-patients with no matched controls were excluded from 
subsequent analyses (Figure 3). Because of differences in 
possible exposures (primarily the use and type of contact 
lens solutions) between soft lens, rigid lens, and non–con-
tact lens users, we further restricted the analysis to case-pa-
tients (n = 72) and controls (n = 140) who reported wearing 
soft contact lenses only. Separate analyses were performed 
among users of rigid contact lenses and non–contact lens 
users; however, sample sizes were small, and no associa-
tions were found. Users of soft contact lenses who were ex-
cluded for lack of a matched control were not significantly 
different from those included in the analysis with respect to 
age, sex, race, and ethnicity.
Matched univariate analysis of users of soft contact 
lenses (online Appendix Table, available from www.cdc.
gov/EID/content/15/8/1236-appT.htm)  indicated  that  any 
use of AMOCMP within the month before symptom onset 
was a substantial risk factor (OR 15.8, 95% CI 5.6–44.6). 
No other contact lens solutions were associated with dis-
ease. Variables in univariate analyses that were included in 
the multivariate modeling included the following: any use 
of AMOCMP, Hispanic ethnicity, age (12–17, 18–24, 25–
34, 35–49, versus >50 years), male sex, history of ocular 
trauma, contact lens use <5 years, frequency of replacing 
old lenses with new ones, swimming in a lake or river while 
wearing lenses, washing the face while wearing lenses, lack 
of hand washing before inserting lenses, cleaning lenses at 
the bathroom sink, failure to always cap the solution bottle 
after use, and ever topping off solution (adding new solu-
tion to old solution in the lens case).
In multivariate analysis, only 3 exposures were statis-
tically significant (Table 2). Case-patients had 16.9 times 
the odds of reporting any use of AMOCMP compared with 
controls (95% CI 4.8–59.5), 2.8 times the odds of reporting 
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Figure 1. Acanthamoeba	keratitis	case-patients	by	state,	USA	(N	
=	105).	*Number	of	interviewed	case-patients	per	state.	Because	
of incomplete case reporting and enrollment in case–control study, 
incidence rates were not calculated. Acanthamoeba Keratitis and Contact Lens Solution
ever topping off solution (95% CI 1.2–6.8), and 2.8 times 
the odds of having used contact lenses for <5 years (95% 
CI 1.0–7.6). Although age and sex were not significantly 
associated with AK in the multivariate analysis, they were 
included in the model to adjust for potential confounding.
Laboratory Investigation
We  received  94  outbreak–related  specimens  from 
case-patients; 10 culture isolates, 4 corneal specimens, and 
80 environmental specimens (48 lenses and/or cases, 32 
bottles of solution, including 5 unopened bottles). Of the 4 
corneal specimens, 1 (25%) was culture positive; that spec-
imen and 2 others (overall 75%) were positive by real-time 
PCR. Among the 48 lenses and/or cases, 11 (23%) were 
positive by culture; real-time PCR detected an additional 
3 positive samples (overall 29%). No bottles of solution 
were culture positive. Five opened AMOCMP bottles were 
positive by real-time PCR. Eight other AMOCMP bottles, 
including 3 that arrived in the laboratory unopened, were 
negative by PCR. The remaining bottles of solution (non-
AMOCMP products) were all PCR negative. Of 22 differ-
ent lot numbers for AMOCMP bottles used by case-patients 
before onset of symptoms, no lot number was repeated.
Acanthamoeba genotyping was performed on 22 out-
break–related isolates; 20 (91%) were T4 genotype, which 
is the most common genotype in the environment as well as 
in AK (11). Two environmental samples contained Acan-
thamoeba genotypes T3 and T14.
Discussion
This investigation of a national AK outbreak identi-
fied use of a single contact lens solution as the primary risk 
factor for infection. AMOCMP is a multipurpose solution 
used for disinfecting, rinsing, cleaning, and storing lenses. 
Our findings indicate that the strong association between 
AMOCMP and AK was unlikely to have resulted from in-
trinsic contamination. Case-patients had a wide geograph-
ic and temporal distribution, and there were no common 
lot numbers among AMOCMP bottles provided by case-
patients. Although 3 opened bottles of AMOCMP tested 
positive  by  PCR  for  Acanthamoeba  spp.,  all  unopened 
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Figure 2. Symptom onset of cases of Acanthamoeba keratitis, by 
month	and	year,	United	States,	2005–2007	(N	=	105). 
Table 1. Demographic and clinical characteristics of 105 patients 
with Acanthamoeba keratitis, United States, 2005–2007 
Characteristic
No.	(%)	
patients
Sex 
  Female  67 (64) 
Age, y* 
  12–17  27 (26) 
  18–24  17 (16) 
  25–34  15 (14) 
  35–49  24 (23) 
>50 22 (21)
Contact lens wear 
  Did not use contact lenses  12 (11) 
  Used contact lenses  93 (89) 
    Lens type 
      Soft lenses  82 (88) 
      Rigid lenses  10 (11) 
      Hybrid lenses  1 (1) 
Contact lens solution use among contact users† 
  Did not use cleaning or disinfecting contact lens
  solution 
6 (6) 
  Used any type of cleaning or disinfecting contact 
  lens solution 
87 (94) 
    Type of solution used‡ 
      Multipurpose solution  78 (90) 
      Hydrogen peroxide solution  6 (7) 
      Daily cleaner  11 (13) 
Affected eye 
  Right  53 (50) 
  Left  44 (42) 
  Both  8 (8) 
Symptoms when treatment sought‡§ 
  Pain  78 (74) 
  Redness  78 (74) 
  Sensitivity to light  76 (72) 
  Sensation of foreign body  71 (68) 
  Increased tearing  59 (56) 
  Blurred vision  57 (54) 
  Discharge from eye  20 (19) 
Clinical status¶ 
  Resolved with pharmacologic therapy  32 (38) 
  Currently receiving pharmacologic therapy  29 (34) 
  Corneal transplant performed  21 (25) 
  Corneal transplant planned  3 (4) 
Most recent visual acuity with best correction in affected eye# 
	 20/20	 17 (24) 
	 20/25–20/100	 24 (34) 
	 20/>200 29 (41)
*Median 29y, range 12–76y. 
†During 1 month before illness onset; n = 93. 
‡Not	mutually	exclusive.		
§Median time from symptom onset to anti-Acanthamoeba therapy (n = 80) 
was 49 d (range 4–197 d). 
¶At the time of treating ophthalmologist interview; n = 85. 
#At the time of treating ophthalmologist interview; n = 70. RESEARCH
bottles were PCR negative, and all AMOCMP bottles were 
negative by culture. The positive PCR results most likely 
represent point-of-use contamination through contact with 
water or dirty hands. We suspect that AMOCMP was in-
sufficiently  active  against  Acanthamoeba  spp.,  resulting 
in increased likelihood of infection among product users. 
The sources of Acanthamoeba spp. could have been varied 
and multiple because Acanthamoeba spp. are ubiquitous in 
the environment. A concurrent AK case–control study con-
ducted in the Chicago area, which investigated 55 separate 
cases, also found AMOCMP to be the most important risk 
factor (9).
AMOCMP was introduced for sale in 2003, just be-
fore the nationwide increase in cases. This product differed 
from AMO Complete, the multipurpose solution that pre-
ceded it, by the addition of propylene glycol (a comfort 
enhancer) and taurine (a buffering agent) (12). After this 
outbreak,  laboratory  investigations  found  that  propylene 
glycol may cause Acanthamoeba trophozoites to encyst, 
thereby  making  them  resistant  to  disinfection  (12,13). 
However, propylene glycol is not unique to AMOCMP and 
is an ingredient of at least 1 other multipurpose solution, as 
well as several brands of artificial tears. Published results 
on the performance of multipurpose solutions, including 
AMOCMP, against Acanthamoeba organisms have shown 
varying efficacy (14–16). Assessment of anti-Acanthamoe-
ba solution efficacy is limited by a lack of standardized 
testing methods (17). FDA guidance and the International 
Organization for Standardization standards do not include 
anti-Acanthamoeba spp. testing (18). However, after this 
outbreak, the Ophthalmic Devices Panel of the FDA Medi-
cal Devices Advisory Committee has recommended adding 
Acanthamoeba spp. as a challenge organism for testing of 
contact lens solutions (19).
Several similarities exist between this AK outbreak and 
the 2006 Fusarium keratitis outbreak (7). Both outbreaks of 
serious corneal infections occurred primarily among users 
of soft contact lenses. The 3–4 year duration of the AK 
outbreak spanned the timeframe of the Fusarium outbreak 
(June 2005–June 2006). In each outbreak, the primary risk 
factor was use of a certain multipurpose solution; Bausch 
and Lomb Renu with MoistureLoc (RML) was recalled in 
April 2006 after its use was identified as a major risk fac-
tor for Fusarium keratitis. Neither investigation found evi-
dence of intrinsic microbial contamination of the solution; 
instead,  insufficient  antimicrobial  efficacy  was  hypothe-
sized to be the primary driving force behind each epidemic. 
In both outbreaks, the practice of topping off solution in 
the lens case also emerged as an important risk factor. Af-
ter the Fusarium keratitis outbreak, tests simulating the re-
ported practices of the case-patients found that topping off 
reduced the antimicrobial efficacy of RML (20). Together, 
these outbreaks raise concern about the safety of multipur-
pose contact lens solutions and related consumer behavior. 
FDA recently discussed these concerns and recommended 
changes to premarket testing and labeling for contact lens 
solutions, including more explicit warnings against topping 
off the solution (19).
This  investigation  yielded  several  notable  nega-
tive findings. No use of contact lens solutions other than 
AMOCMP was identified as a risk factor, including the 1 
other multipurpose solution that contained propylene gly-
col.  Contact  lens  characteristics  that  have  been  hypoth-
esized to increase the risk for AK, such as lens material 
and FDA lens group (21,22), were not associated with AK 
in this study; nor was there statistical interaction between 
use of AMOCMP and characteristics of soft contact lenses. 
Although rubbing and rinsing of lenses during the disin-
fection process have been shown in laboratory studies to 
decrease Acanthamoeba contamination of lenses (23), we 
did not find these practices to be protective. Although poor 
contact lens hygiene is widely recognized as a risk factor 
for AK (24–26), in this study only the topping off of old so-
lution emerged as an important behavioral risk factor. We 
speculate that the association between AK and contact lens 
use for <5 years may reflect a wide range of poor hygiene 
practices among new contact lens users. Individual hygiene 
lapses may not be prevalent enough to emerge as important 
risk factors, but in aggregate, poor hygiene practices might 
be more common among users of new lenses.
We also found that a wide range of behaviors that can 
result in exposure of contact lenses to water (e.g., shower-
ing with lenses in, rinsing lenses or cases with tap water) 
was not associated with AK in this study. Although such 
practices are generally considered to be important risk fac-
tors for AK (2,24,26), a separate case–control study among 
contact lens users found that water exposure was not a risk 
factor (27).
Some researchers have suggested that municipal wa-
ter treatment type may play a role in the development of 
AK (28). Acanthamoeba organisms are present in the water 
of many households (29–32). A temporal association was 
noted between an increase in AK cases in the Chicago area 
(28) and the implementation of the Environmental Protec-
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Figure 3. Matching of case-patients with Acanthamoeba keratitis 
and controls, United States, 2005–2007. Acanthamoeba Keratitis and Contact Lens Solution
tion  Agency  Disinfectants  and  Disinfection  Byproducts 
Rule, which was aimed at decreasing potentially harmful 
disinfection byproducts in water (33). To comply with this 
rule, many municipal water supply systems have switched 
from using chlorine to using chloramine as a residual drink-
ing water disinfectant. However, no change in water disin-
fection type was made by the Chicago Department of Wa-
ter Management during the period of interest. Chicago-area 
water has been continuously disinfected with chlorine for 
>30 years (A. Stark, City of Chicago Department of Water 
Management, pers. comm.). A preliminary analysis (J. Ve-
rani, unpub. data) conducted during the early phase of this 
investigation found that only 12 (29%) of 41 case-patients 
for  whom  water  treatment  data  were  available  received 
household water from chloraminated systems during the 
month before symptom onset, compared with an estimated 
32% of the general US population (34,35). These findings 
suggested that water disinfection type was not an important 
risk factor in this outbreak.
This study had several limitations. First, because AK 
culture is a highly specific, but insensitive, diagnostic tool 
(36), and because preferred diagnostic methods vary by 
medical  center,  inclusion  of  only  patients  with  culture-
confirmed cases may have introduced regional testing bias 
and  underestimated  the  scope  of  the  outbreak.  Second, 
the response rate among persons approached for control 
interviews  was  low;  therefore,  demographic  differences 
between cases and controls may have been due to selec-
tion bias among controls. Third, recall bias may have been 
introduced as we asked participants to report on contact 
lens product use and behavior during the previous 2 years. 
Fourth, misclassification bias may have been introduced 
because at least 2 case-patients appeared to not differenti-
ate between use of saline and cleaning or disinfecting solu-
tions. Fifth, because >40% of case-patients and all controls 
were  interviewed  after  AMOCMP  was  recalled  in  May 
2007, reporting bias may have been introduced.
Despite  these  limitations,  among  users  of  soft  con-
tact  lenses,  case-patients  had  almost  17  times  the  odds 
of reporting any AMOCMP use compared with matched 
controls, validating the results of the preliminary analysis 
comparing AK cases to Fusarium keratitis investigation 
controls (8). The use of this existing Fusarium compari-
son data enabled rapid public health action months before 
the case–control study was completed. Recent associations 
of 2 distinct multipurpose solutions with outbreaks of rare 
corneal infections highlight the need for improved surveil-
lance to promptly detect contact lens–related outbreaks and 
raise concerns about the effectiveness of multipurpose so-
lutions. Continued monitoring of AK case trends to assess 
the impact of the AMOCMP recall and research on the anti-
Acanthamoeba efficacy of AMOCMP and other solutions 
are under way. Our findings highlight the importance of 
promoting healthy habits among contact lens users, par-
ticularly discouraging the practice of topping off solutions 
and reinforcing safe hygienic practices among new users 
of contact lenses, as well as the need for standardized anti-
Acanthamoeba testing of contact lens solutions.
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